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Materials and Methods 
Experimental protocol 
The GAM experiment was performed as a single dose parallel study, with 2 groups of six 
4-week-old female broiler chickens. The animals received a bolus of 6.0 mg/kg body 
weight GAM (Zactran®, Merial, see Fig. 2) intravenously (IV) in the wing vein or 
subcutaneously (SC) at the neck. Blood (1 mL) was sampled by venipuncture from the leg 
vein before (time 0) and post-administration (0.25, 0.5, 0.75, 1, 2, 4, 6, 8, 10, 12 and 24 
hours, once daily from day 2 till day 10 and once on day 12 and 14). Plasma was stored 
at ≤ -15°C until analysis.  
 
GAM analysis 
Quantitation of GAM in plasma was carried out using a liquid chromatography-tandem 
mass spectometry (LC-MS/MS) method. The sample preparation is shown in Fig 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Diagram of GAM sample preparation      Figure 2. Chemical structure of GAM 
steps before LC-MS/MS analysis 
  
 
PK and Statistical analysis 
The PK parameters were analyzed using WinNonlin, version 6.2.0 (Pharsight). A two-
compartmental model was used to determine AUC0∞, kabs, kel α and kel β, T1/2abs,T1/2el α and 
T1/2el β (expressed as the harmonic mean), Vd, Cl, C0, Cmax and Tmax.  
The absolute bioavailability (F) was calculated from the following equation:  
F (%) = (AUC0∞ SC / AUC0∞ IV ) × 100 
The data were statistically analysed by means of single-factor analysis of variance 
(ANOVA), using PASW Statistics 19 (IBM SPSS software). A value of P<0.05 was 
considered significant. 
Parameter Units IV SC 
AUC0∞ h.ng/mL 3998.1 ± 1060.1 4094.7 ± 1645.1 
kabs /h - 32.70 ± 13.41 
kel α /h 7.69 ± 2.35 2.02 ± 0.67
* 
kel β /h 0.049 ± 0.010 0.060 ± 0.035 
T1/2abs h - 0.021
A 
T1/2el α h 0.90
A 0.34A* 
T1/2el β h 14.12
A 11.63A 
Vss L/kg 29.16 ± 7.20 - 
V1 L/kg 2.09 ± 1.26 6.67 ± 2.82
* 
V2 L/kg 27.08 ± 7.41 20.89 ± 7.48 
Cl L/h.kg 1.61 ± 0.52 1.77 ± 0.98 
Tmax h - 0.13 ± 0.04 
C0 ng/mL 3627.0 ± 1805.0 - 
Cmax ng/mL - 889.5 ± 382.1 
F % - 102.4 ± 50.97 
Results 
The semi-logarithmic plots of the plasma concentration-time curves after IV 
and SC administration are depicted in Fig. 3. 
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Discussion and Conclusion 
There are significant differences between the IV and SC administration for kel α, T1/2el α and 
V1, which is obvious as the absorption after a SC bolus confounds the distribution phase. 
The volume of distribution is very high and comparable with cattle. This leads to a high 
penetration in tissue. The high clearance in chickens resulted in a shorter T1/2el β in 
comparison with cattle (14.1 and 44.9 h after IV administration, respectively in chicken 
and cattle).  
We can conclude that there is a fast and complete absorption of GAM after SC 
administration (F = 102%) with a good penetration into tissue, which is 
important to treat respiratory diseases. 
 
The pharmacokinetic parameters here presented, will be 
useful for future pharmacodynamic studies of inflammatory 
diseases in broiler chickens because of its possible anti-
inflammatory acting. Although, the application in poultry 
industry is not very plausible because of the long 
elimination, with sustained residues. 
Figure 3. Mean (±SD) plasma concentration-time profiles of gamithromycin after 
IV (n=6) and SC (n=6) bolus administration of 6.0 mg/kg BW in broiler chickens 
Table 1. Pharmacokinetic parameters for gamithromycin in broiler chickens after 
IV (n=6) and SC (n=6) bolus administration of 6.0 mg/kg BW (mean ±SD) 
A: harmonic mean 
*: significant difference (P<0.05) 
Introduction 
Gamithromycin (GAM) is a 15-membered semi-synthetic macrolide, which is effective against bovine respiratory disease. Since this drug is currently only registered for 
cattle, data on other species are rare. GAM could have a positive effect on respiratory disorders in chickens, for instance in infection of Mycoplasma gallisepticum. Moreover, 
it is stated that macrolides may have immunomodulating capacities. To investigate these immunomodulating properties of GAM in a lipopolysaccharide inflammation model 
in broilers, it is important to determine the pharmacokinetics. Data on the disposition of this drug in broilers are indeed unknown. Therefore, the aim of this study was to 
investigate several pharmacokinetic (PK) parameters (area under the curve, AUC; absorption and elimination rate constants, kabs, kel α and kel β; half-lifes of absorption and 
elimination, T1/2abs,T1/2el α and T1/2el β; volume of distribution, Vd; clearance, Cl; plasma concentration at time 0, C0; maximum plasma concentration, Cmax; and time to Cmax, 
Tmax) of GAM in healthy broiler chickens. 
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